Tamirisa, Kamala P <br/><br/>
Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.  [electronic resource] 

 -  American heart journal  Dec 2004 
 - 971-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2004.10.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Age Factors<br/>Aged<br/>Algorithms<br/>Body Weight<br/>Case-Control Studies<br/>Creatinine--blood<br/>Diabetes Complications<br/>Diuretics--therapeutic use<br/>Female<br/>Heart Failure--blood<br/>Humans<br/>Hyperkalemia--chemically induced<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--adverse effects<br/>Potassium--blood<br/>Renal Insufficiency--chemically induced<br/>Risk Factors<br/>Spironolactone--adverse effects